Status:
ACTIVE_NOT_RECRUITING
MHealth HIV Prevention for Transgender Women
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study aims to inform the development of an acceptable and usable smartphone app for transgender women (TGW) in Malaysia to deliver an integrated HIV prevention intervention that incorporates scre...
Detailed Description
This study aims to inform the development of an acceptable and usable smartphone app for transgender women (TGW) in Malaysia to deliver an integrated HIV prevention intervention that incorporates scre...
Eligibility Criteria
Inclusion
- HIV-negative
- Identify as a transgender woman
- Condomless sex in the last 30 days
- Own a smartphone
Exclusion
- Unable to provide informed consent
- Unable to read and understand English or Bahasa Malaysia
Key Trial Info
Start Date :
July 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05271097
Start Date
July 12 2023
End Date
March 1 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Malaya
Kuala Lumpur, Malaysia, 50603